Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

865 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety evaluation of immune-cell therapy for malignant tumor in the Cancer Immune-cell Therapy Evaluation Group (CITEG).
Takimoto R, Kamigaki T, Ito H, Saito M, Takizawa K, Soejima K, Yasuda H, Ohgino K, Terai H, Tomita K, Miura M, Mizukoshi E, Miyashita T, Nakamoto Y, Hayashi K, Miwa S, Kitahara M, Takeuchi A, Kimura H, Mochizuki T, Sugie H, Seino KI, Yamada T, Takeuchi S, Makita K, Naitoh K, Yasumoto K, Yoshida Y, Inoue H, Kotake K, Ohshima K, Noda SE, Okamoto M, Yoshimoto Y, Okada S, Ibe H, Oguma E, Goto S; CITEG. Takimoto R, et al. Among authors: nakamoto y. Cytotherapy. 2023 Nov;25(11):1229-1235. doi: 10.1016/j.jcyt.2023.06.007. Epub 2023 Jul 22. Cytotherapy. 2023. PMID: 37486281 Free article.
Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis: QUASAR Phase 2b Induction Study.
Peyrin-Biroulet L, Allegretti JR, Rubin DT, Bressler B, Germinaro M, Huang KG, Shipitofsky N, Zhang H, Wilson R, Han C, Feagan BG, Sandborn WJ, Panés J, Hisamatsu T, Lichtenstein GR, Sands BE, Dignass A; QUASAR Study Group. Peyrin-Biroulet L, et al. Gastroenterology. 2023 Dec;165(6):1443-1457. doi: 10.1053/j.gastro.2023.08.038. Epub 2023 Sep 1. Gastroenterology. 2023. PMID: 37659673 Free article. Clinical Trial.
Programmed Death Ligand 1 Expression in Circulating Tumor Cells as a Predictor and Monitor of Response to Atezolizumab plus Bevacizumab Treatment in Patients with Hepatocellular Carcinoma.
Nosaka T, Murata Y, Akazawa Y, Tanaka T, Takahashi K, Naito T, Matsuda H, Ohtani M, Imamura Y, Nakamoto Y. Nosaka T, et al. Among authors: nakamoto y. Cancers (Basel). 2024 May 6;16(9):1785. doi: 10.3390/cancers16091785. Cancers (Basel). 2024. PMID: 38730737 Free PMC article.
Spatial Pattern of Intraprostatic Recurrence after Definitive External-Beam Radiation Therapy for Prostate Cancer: Implications for Focal Boost to Intraprostatic Dominant Lesion.
Aizawa R, Otani T, Ogata T, Moribata Y, Kido A, Akamatsu S, Goto T, Masui K, Sumiyoshi T, Kita Y, Kobayashi T, Nakamoto Y, Mizowaki T. Aizawa R, et al. Among authors: nakamoto y. Adv Radiat Oncol. 2024 Mar 13;9(6):101489. doi: 10.1016/j.adro.2024.101489. eCollection 2024 Jun. Adv Radiat Oncol. 2024. PMID: 38681892 Free PMC article.
Clinical and imaging characteristics of supratentorial glioma with IDH2 mutation.
Ikeda S, Sakata A, Arakawa Y, Mineharu Y, Makino Y, Takeuchi Y, Fushimi Y, Okuchi S, Nakajima S, Otani S, Nakamoto Y. Ikeda S, et al. Among authors: nakamoto y. Neuroradiology. 2024 Jun;66(6):973-981. doi: 10.1007/s00234-024-03361-8. Epub 2024 Apr 24. Neuroradiology. 2024. PMID: 38653782
865 results